SGMT
Sagimet Biosciences Inc.
$6.81
+$0.29(+4.45%)
58
Overall
--
Value
58
Tech
--
Quality
Market Cap
$212.04M
Volume
629.01K
52W Range
$1.73 - $11.41
Target Price
$25.50
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|
| REVENUE | |||||
| Total Revenue | -- | $2.0M | -- | ||
| Total Revenue | -- | $2.0M | -- | ||
| GROSS PROFIT | |||||
| Gross Profit | -- | $2.0M | -- | ||
| OPERATING EXPENSES | |||||
| Operating Expenses | $31.1M | $32.7M | $54.5M | ||
| Research & Development | $24.9M | $19.8M | $38.4M | ||
| Research Expense | -- | $19.8M | $38.4M | ||
| Selling, General & Administrative | $6.1M | $13.0M | $16.0M | ||
| General & Administrative Expenses | $6.1M | $13.0M | $16.0M | ||
| Salaries & Wages | -- | $5.0M | $5.3M | ||
| Other Operating Expenses | -- | $-250.0K | $-653.0K | ||
| OPERATING INCOME | |||||
| Operating income | $-31.1M | $-30.7M | $-54.5M | ||
| EBITDA | -- | $-27.9M | $-45.6M | ||
| NON-OPERATING ITEMS | |||||
| Intinc | $553.0K | $2.9M | $8.9M | ||
| Net Non-Operating Interest Income/Expense | $553.0K | $2.9M | $8.9M | ||
| Other Income/Expense | $-3.0K | $-4.0K | -- | ||
| Other Special Charges | -- | $4.0K | -- | ||
| PRE-TAX INCOME | |||||
| EBIT | -- | $-27.9M | $-45.6M | ||
| Pre-Tax Income | $-30.5M | $-27.9M | $-45.6M | ||
| NET INCOME | |||||
| Net Income | $-30.5M | $-27.9M | $-45.6M | ||
| Net Income (Continuing Operations) | $-30.5M | $-27.9M | $-45.6M | ||
| Net Income (Discontinued Operations) | $-30.5M | $-27.9M | $-45.6M | ||
| Net Income (Common Stockholders) | $-30.5M | $-27.9M | $-45.6M | ||
| Normalized Income | -- | -- | $-45.1M | ||
| TOTALS | |||||
| Total Expenses | $31.1M | $32.7M | $54.5M | ||
| SHARE & EPS DATA | |||||
| Average Shares Outstanding | $184.6K | $10.5M | $31.4M | ||
| Average Shares Outstanding (Diluted) | $184.6K | $10.5M | $31.4M | ||
| Shares Outstanding | $31.0M | $31.9M | $32.2M | ||
| Basic EPS | $-165.2 | $-2.66 | $-1.45 | ||
| Basic EPS (Continuing Operations) | $-165.2 | $-2.66 | $-1.45 | ||
| Diluted EPS | $-165.2 | $-2.66 | $-1.45 | ||
| Diluted EPS (Continuing Operations) | $-165.2 | $-2.66 | $-1.45 | ||
| OTHER METRICS | |||||
| Other Gand A | $6.1M | $13.0M | $16.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SGMT | $6.81 | +4.4% | 629.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Sagimet Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW